0000899243-21-047572.txt : 20211209
0000899243-21-047572.hdr.sgml : 20211209
20211209171513
ACCESSION NUMBER: 0000899243-21-047572
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211208
FILED AS OF DATE: 20211209
DATE AS OF CHANGE: 20211209
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canaan XI L.P.
CENTRAL INDEX KEY: 0001712417
STATE OF INCORPORATION: E9
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40431
FILM NUMBER: 211482785
BUSINESS ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE
STREET 2: SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: 203-855-0400
MAIL ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE
STREET 2: SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Canaan Partners XI LLC
CENTRAL INDEX KEY: 0001850694
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40431
FILM NUMBER: 211482784
BUSINESS ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE, SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
BUSINESS PHONE: 203-855-0400
MAIL ADDRESS:
STREET 1: 285 RIVERSIDE AVENUE, SUITE 250
CITY: WESTPORT
STATE: CT
ZIP: 06880
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Day One Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001845337
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 832415215
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 395 OYSTER POINT BLVD STE 217
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-1930
BUSINESS PHONE: 206-913-4300
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BLVD STE 217
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080-1930
FORMER COMPANY:
FORMER CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC
DATE OF NAME CHANGE: 20210209
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-08
0
0001845337
Day One Biopharmaceuticals, Inc.
DAWN
0001712417
Canaan XI L.P.
285 RIVERSIDE AVENUE, SUITE 250
WESTPORT
CT
06880
0
0
1
0
0001850694
Canaan Partners XI LLC
285 RIVERSIDE AVENUE, SUITE 250
WESTPORT
CT
06880
0
0
1
0
Common Stock
2021-12-08
4
J
0
536000
D
10199645
D
On December 8, 2021, Canaan XI L.P. (the "Canaan Fund") distributed, for no consideration, 536,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Canaan Partners XI LLC ("Canaan XI"), the general partner of the Canaan Fund, representing each such partner's pro rata interest in the shares held by the Canaan Fund. On the same date, Canaan XI distributed, for no consideration, the Shares it received from the distribution to its members in an amount equal to each such member's pro rata interest in the Shares. The aforementioned distributions were made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended.
These shares are held directly by the Canaan Fund. Canaan XI is the sole general partner of the Canaan Fund and may be deemed to have sole voting, investment and dispositive power with respect to the shares held by the Canaan Fund. Canaan XI disclaims Section 16 beneficial ownership of the securities held by the Canaan Fund, except to the extent of its pecuniary interest therein, if any.
Canaan XI L.P., By: Canaan Partners XI LLC, its general partner, By: /s/ Nancy Levenson, Attorney-in-Fact
2021-12-09
Canaan Partners XI LLC, By: /s/ Nancy Levenson, Attorney-in-Fact
2021-12-09